PathoVax LLC
PrivateLast Round
Grant
Jul 23, 2020
Total Funding Raised
$2.08M
Company Overview
PathoVax LLC operates in Healthcare & Life Sciences and is based in Baltimore, Maryland. Its latest recorded funding round was a Grant round in July 2020.
PathoVax LLC is a biotechnology company that develops universal prophylactic vaccines targeting human papillomavirus (HPV) strains.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PathoVax LLC Comparables
Compare PathoVax LLC with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Flow Pharma, Inc. | 81% | |
| 2A Pharma | 79% | |
| VLP the Vaccines Company | 78% |
For institutional investors. Book with your work email.
PathoVax LLC Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 23, 2020 | ||||
| Grant | Jul 23, 2020 | ||||
| Grant | Sep 1, 2018 | ||||
| Accelerator | Oct 27, 2016 | ||||
| Grant | Mar 1, 2016 | ||||
Grant | Apr 1, 2015 |
For institutional investors. Book with your work email.
PathoVax LLC Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| TEDCO | Grant |
| Johns Hopkins University Endowment | Grant |
| 43North | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 23, 2020
$874K grant received from the National Cancer Institute.
- Mar 1, 2016
$100K raised from TEDCO and Maryland Innovation Initiative.
For institutional investors. Book with your work email.
PathoVax LLC Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PathoVax LLC's valuation, stock price, and market status.
Is PathoVax LLC a public or private company?
PathoVax LLC is a private company.
What is the current stock price of PathoVax LLC?
PathoVax LLC is a private company, so its shares have no public market price. Caplight tracks PathoVax LLC's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PathoVax LLC worth (valuation)?
Valuation information for PathoVax LLC is not publicly available.
Can I buy PathoVax LLC stock?
PathoVax LLC shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PathoVax LLC's last funding round?
PathoVax LLC's most recent funding round was Grant on July 23, 2020.
Who are the main investors in PathoVax LLC?
Key investors in PathoVax LLC include National Cancer Institute, TEDCO, Johns Hopkins University Endowment, 43North.
Will PathoVax LLC IPO soon?
No public IPO plans have been announced for PathoVax LLC.
How can I track PathoVax LLC secondary market activity?
Caplight tracks bids, offers, and trades in PathoVax LLC's shares on secondary markets.